Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongfeng Qu

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cancers|December 28, 2019
DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal CancersSripathi M Sureban, Robert Berahovich, Hua Zhou, et al.
Scientific Reports|November 24, 2016
Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injuryParthasarathy Chandrakesan, Randal May, Nathaniel Weygant, et al.
International Journal of Molecular Sciences|June 27, 2024
From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver DiseasesLandon L Moore, Dongfeng Qu, Sripathi Sureban, et al.
Oncotarget|October 16, 2015
Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanismSripathi M Sureban, Mohammad F Madhoun, Randal May, et al.
Plos One|August 14, 2015
Dietary Pectin Increases Intestinal Crypt Stem Cell Survival following Radiation InjurySripathi M Sureban, Randal May, Dongfeng Qu, et al.
Molecular Cancer Therapeutics|May 7, 2020
DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage PolarizationParthasarathy Chandrakesan, Janani Panneerselvam, Randal May, et al.
Plos One|September 17, 2013
DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancerSripathi M Sureban, Randal May, Dongfeng Qu, et al.
Cancer Letters|June 1, 2014
XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanismSripathi M Sureban, Randal May, Nathaniel Weygant, et al.
Digestive Diseases and Sciences|October 7, 2014
DCLK1 is detectable in plasma of patients with Barrett's esophagus and esophageal adenocarcinomaJoshua Whorton, Sripathi M Sureban, Randal May, et al.
Acta Biochimica Et Biophysica Sinica|May 13, 2020
Reverse engineering a predictive signature characterized by proliferation, DNA damage, and immune escape from stage I lung adenocarcinoma recurrenceJiannan Yao, Xinying Xue, Dongfeng Qu, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancers|December 28, 2019
DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal CancersSripathi M Sureban, Robert Berahovich, Hua Zhou, et al.
Scientific Reports|November 24, 2016
Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injuryParthasarathy Chandrakesan, Randal May, Nathaniel Weygant, et al.
International Journal of Molecular Sciences|June 27, 2024
From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver DiseasesLandon L Moore, Dongfeng Qu, Sripathi Sureban, et al.
Oncotarget|October 16, 2015
Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanismSripathi M Sureban, Mohammad F Madhoun, Randal May, et al.
Plos One|August 14, 2015
Dietary Pectin Increases Intestinal Crypt Stem Cell Survival following Radiation InjurySripathi M Sureban, Randal May, Dongfeng Qu, et al.
Molecular Cancer Therapeutics|May 7, 2020
DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage PolarizationParthasarathy Chandrakesan, Janani Panneerselvam, Randal May, et al.
Plos One|September 17, 2013
DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancerSripathi M Sureban, Randal May, Dongfeng Qu, et al.
Cancer Letters|June 1, 2014
XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanismSripathi M Sureban, Randal May, Nathaniel Weygant, et al.
Digestive Diseases and Sciences|October 7, 2014
DCLK1 is detectable in plasma of patients with Barrett's esophagus and esophageal adenocarcinomaJoshua Whorton, Sripathi M Sureban, Randal May, et al.
Acta Biochimica Et Biophysica Sinica|May 13, 2020
Reverse engineering a predictive signature characterized by proliferation, DNA damage, and immune escape from stage I lung adenocarcinoma recurrenceJiannan Yao, Xinying Xue, Dongfeng Qu, et al.
Pageof 5